Related Experiment Video

Updated: Mar 21, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

8.1K

Allosteric inhibition of antiapoptotic MCL-1

Susan Lee1,2, Thomas E Wales3, Silvia Escudero1,2

  • 1Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Nature Structural & Molecular Biology
|May 10, 2016
PubMed

Insights

Scientists discovered a new way to inhibit MCL-1, a protein driving cancer growth. By targeting a different site than previously thought, they found a novel strategy to disarm MCL-1 and fight cancer.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • MCL-1 is a key antiapoptotic protein in the BCL-2 family, crucial for cancer cell survival.
  • Cancer cells exploit MCL-1 to block apoptosis, making them resistant to treatment.
  • Targeting the BH3-binding groove of MCL-1 has been difficult, unlike BCL-2.

Purpose of the Study:

  • To explore alternative strategies for inhibiting MCL-1 beyond the BH3-binding groove.
  • To identify novel small-molecule interactions for disrupting MCL-1's antiapoptotic function.
  • To develop new therapeutic approaches for cancers driven by MCL-1.

Main Methods:

  • Small-molecule covalent modification of MCL-1 at C286.
  • Structure-function analyses to understand molecular interactions.
  • In vitro and in vivo studies using mutagenic mimicry (C286W) in mouse cells.

Main Results:

  • A novel interaction site on MCL-1, distinct from the BH3-binding groove, was identified.
  • Small-molecule engagement at C286 allosterically impairs MCL-1's BH3 binding and BAX suppression.
  • C286W mutation phenocopied the effects of molecular engagement, validating the allosteric mechanism.

Conclusions:

  • An allosteric mechanism for inhibiting MCL-1 has been characterized.
  • Targeting C286 offers a new strategy for disarming MCL-1 in cancer therapy.
  • This discovery opens new avenues for developing anti-cancer drugs against MCL-1.

More Related Videos

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

1.0K
Identifying Protein-protein Interaction Sites Using Peptide Arrays07:44

Identifying Protein-protein Interaction Sites Using Peptide Arrays

Published on: November 18, 2014

18.7K

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.1K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.9K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
16.7K